Arclight Therapeutics

Crucible Therapeutics

This biotechnology company develops RNA-based therapies for patients with neurodegenerative conditions such as amyotrophic lateral sclerosis and frontotemporal dementia.

Yumanity Therapeutics

This company develops small molecule drugs to treat neurodegenerative diseases for patients with conditions such as Parkinson's disease and amyotrophic lateral sclerosis.

AZ Therapies

This biopharmaceutical company develops therapies for neurodegenerative diseases, including Alzheimer's disease and ischaemic stroke, to treat patients and improve their cognitive health.

Axcelius I/II

This company creation vehicle establishes and incubates biopharmaceutical firms developing treatments for cancer, rare diseases and neurodegenerative disorders.

CuraSen Therapeutics

This biopharmaceutical company develops small molecule drugs to treat patients with neurodegenerative disorders, such as Parkinson's and Alzheimer's disease.

Scripta Therapeutics

The company develops therapeutics that modulate transcription factor activity to treat neurodegenerative diseases for patients with conditions such as Alzheimer's and Parkinson's.

NeurOdys Therapeutics

This biotechnology company develops small molecule therapies for patients with neurodegenerative conditions such as Alzheimer's and Parkinson's diseases.

MindImmune

This pharmaceutical company develops immunomodulatory monoclonal antibodies to treat patients suffering from neurodegenerative diseases like Alzheimer's by targeting brain inflammation.